Zentalis Pharmaceuticals (ZNTL) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.24
-0.78
-0.32
0.14

Details

Expected EPS
-0.909678
Actual EPS
-0.56
Surprise EPS
0.35
Surprise Percent
+38.44%

Description

Zentalis Pharmaceuticals (ZNTL) has reported earnings of -0.56 per share for Q4 2024.

0 Comments

Share your thoughts